[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Cao, W., Shao, Y., Wang, N., et al. (2022) Pretreatment Red Blood Cell Distribution Width May Be a Potential Biomarker of Prognosis in Urologic Cancer: A Systematic Review and Me-ta-Analysis. Biomarkers in Medicine, 16, 1289-1300.
https://doi.org/10.2217/bmm-2022-0409
|
[3]
|
Singh, N., Baby, D., Rajguru, J.P., Patil, P.B., Thakkannavar, S.S. and Pujari, V.B. (2019) Inflammation and Cancer. Annals of African Medicine, 18, 121-126. https://doi.org/10.4103/aam.aam_56_18
|
[4]
|
Han, F., Liu, Y., Cheng, S., et al. (2018) Diagnosis and Survival Values of Neutrophil-Lymphocyte Ratio (NLR) and Red Blood Cell Distribution Width (RDW) in Esophageal Cancer. Clinica Chimica Acta, 488, 150-158.
https://doi.org/10.1016/j.cca.2018.10.042
|
[5]
|
Tian, Y., Cheng, C., Wei, Y., et al. (2022) The Role of Exosomes in Inflammatory Diseases and Tumor-Relate Inflammation. Cells, 11, 1005. https://doi.org/10.3390/cells11061005
|
[6]
|
Liao, C.K., Yu, Y.L., Lin, Y.C., et al. (2021) Prognostic Value of the C-Reactive Protein to Albumin Ratio in Colorectal Cancer: An Updated Systematic Review and Meta-Analysis. World Journal of Surgical Oncology, 19, Article No. 139. https://doi.org/10.1186/s12957-021-02253-y
|
[7]
|
Utsumi, M., Inagaki, M., Kitada, K., et al. (2023) Preoperative C-Reactive Protein-to-Albumin Ratio as a Prognostic Factor in Biliary Tract Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 102, e33656.
https://doi.org/10.1097/MD.0000000000033656
|
[8]
|
Rizo-Téllez, S.A., Sekheri, M. and Filep, J.G. (2023) C-Reactive Protein: A Target for Therapy to Reduce Inflammation. Frontiers in Immunology, 14, Article ID: 1237729. https://doi.org/10.3389/fimmu.2023.1237729
|
[9]
|
Kiely, M., Lord, B. and Ambs, S. (2022) Immune Response and Inflammation in Cancer Health Disparities. Trends in Cancer, 8, 316-327. https://doi.org/10.1016/j.trecan.2021.11.010
|
[10]
|
Messerich, N.M., Uda, N.R., Volken, T., et al. (2023) CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study. Cancers (Basel), 15, Article No. 1479. https://doi.org/10.3390/cancers15051479
|
[11]
|
Kwon, C.H., Seo, H.I., Kim, D.U., et al. (2023) Clinical Significance of C-Reactive Protein-to-Prealbumin Ratio in Predicting Early Recurrence in Resectable Pancreatic Cancer. Korean Journal of Clinical Oncology, 19, 11-17.
https://doi.org/10.14216/kjco.23003
|
[12]
|
Guo, S., He, X., Chen, Q., et al. (2017) The C-Reactive Protein/Albumin Ratio, a Validated Prognostic Score, Predicts Outcome of Surgical Renal Cell Carcinoma Patients. BMC Cancer, 17, Ar-ticle No. 171.
https://doi.org/10.1186/s12885-017-3119-6
|
[13]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2021) Cancer Sta-tistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[14]
|
Wu, S., Ma, X., Liang, Z., et al. (2023) Development and Validation of a Nomogram for Predicting Osteoporosis in Prostate Cancer Patients: A Cross-Sectional Study from China. Prostate, 83, 1537-1548.
https://doi.org/10.1002/pros.24612
|
[15]
|
Zhou, B.G., Yu, Q., Jiang, X., et al. (2023) Association between Inflam-matory Bowel Disease and Risk of Incident Prostate Cancer: A Systematic Review and Meta-Analysis of Cohort Studies. International Journal of Colorectal Disease, 38, Article No. 168. https://doi.org/10.1007/s00384-023-04465-y
|
[16]
|
李文, 王光策. 炎症反应在前列腺癌骨转移中的作用研究进展[J]. 现代泌尿生殖肿瘤杂志, 2023, 15(1) 61-64.
|
[17]
|
Mitsui, Y., Yamabe, F., Hori, S., et al. (2023) Combination of C-Reactive Protein/Albumin Ratio and Time to Castration Resistance Enhances Prediction of Prognosis for Patients with Metastatic Castration-Resistant Prostate Cancer. Frontiers in Oncology, 13, Article ID: 1162820. https://doi.org/10.3389/fonc.2023.1162820
|
[18]
|
Uchimoto, T., Komura, K., Fujiwara, Y., et al. (2019) Prognostic Impact of C-Reactive Protein-Albumin Ratio for the Lethality in Castration-Resistant Prostate Cancer. Medical Oncology, 37, Article No. 9.
https://doi.org/10.1007/s12032-019-1332-7
|
[19]
|
李景荣. C反应蛋白与白蛋白比值在泌尿系统恶性肿瘤预后中的作用的Meta分析[D]: [硕士学位论文]. 福州: 福建医科大学, 2023.
|
[20]
|
Lorigo, J., Tavares Silva, E., Pedroso, L.J., et al. (2023) C Reactive Protein/Albumin Ratio as Predictor of Prognosis in Castration Resistant Metastatic Prostate Cancer. Archivio Italiano di Urologia e Andrologia, 95, 11242.
https://doi.org/10.4081/aiua.2023.11242
|
[21]
|
Bahadoram, S., Davoodi, M., Hassanzadeh, S., et al. (2022) Renal Cell Carcinoma: An Overview of the Epidemiology, Diagnosis, and Treatment. Giornale Italiano di Nefrologia, 39, No. 3.
|
[22]
|
Choi, Y., Park, B., Jeong, B.C., et al. (2013) Body Mass Index and Survival in Patients with Renal Cell Carci-noma: A Clinical-Based Cohort and Meta-Analysis. International Journal of Cancer, 132, 625-634.
https://doi.org/10.1002/ijc.27639
|
[23]
|
陈峰, 陈益金, 邹永胜, 等. 术前预后营养指数, 白蛋白/碱性磷酸酶比值对肾癌患者预后的评估价值[J]. 局解手术学杂志, 2021, 30(11): 965-970.
|
[24]
|
Zhou, W. and Zhang, G. (2019) C-Reactive Protein to Albumin Ratio Predicts the Outcome in Renal Cell Carcinoma: A Meta-Analysis. PLOS ONE, 14, e0224266. https://doi.org/10.1371/journal.pone.0224266
|
[25]
|
Gao, J., Agizamhan, S., Zhao, X., et al. (2019) Pre-operative C-Reactive Protein/Albumin Ratio Predicts Outcome of Surgical Papillary Renal Cell Carcinoma. Future On-cology, 15, 1459-1468. https://doi.org/10.2217/fon-2018-0611
|
[26]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[27]
|
Bhindi, B., Kool, R., Kulkarni, G.S., et al. (2021) Canadian Urological Association Guideline on the Management of Non-Muscle-Invasive Bladder Cancer-Abridged Version. Canadian Uro-logical Association Journal, 15, 230-239.
https://doi.org/10.5489/cuaj.7487
|
[28]
|
Teoh, J.Y., Kamat, A.M., Black, P.C., et al. (2022) Recurrence Mechanisms of Non-Muscle-Invasive Bladder Cancer—A Clinical Perspective. Nature Reviews Urology, 19, 280-294. https://doi.org/10.1038/s41585-022-00578-1
|
[29]
|
Moon, S., Pandya, V., McDonald, A., et al. (2023) Analysis of Treatment of Muscle Invasive Bladder Cancer Using the National Cancer Database: Factors Associated with Receipt of Aggressive Therapy. Urologic Oncology.
|
[30]
|
Meng, L., Yang, Y., Hu, X., Zhang, R. and Li, X. (2023) Prognostic Value of the Pretreatment Systemic Immune- Inflammation Index in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis. Journal of Translational Medicine, 21, Article No. 79. https://doi.org/10.1186/s12967-023-03924-y
|
[31]
|
Kuroda, K., Tasaki, S., Horiguchi, A., et al. (2021) Postoperative Creative Protein to Albumin Ratio Predicts Poor Prognosis in Patients with Bladder Cancer Undergoing Radial Cystec-tomy. Molecular and Clinical Oncology, 14, Article No. 54. https://doi.org/10.3892/mco.2021.2216
|
[32]
|
Guo, Y.D., et al. (2018) Preoperative C-Reactive Protein/Albumin Ratio Is a Significant Predictor of Survival in Bladder Can-cer Patients after Radical Cystectomy: A Retrospective Study. Cancer Management and Research, 23, 4789- 4804. https://doi.org/10.2147/CMAR.S180301
|
[33]
|
郭亮, 马曜辉, 管庆军, 等. C反应蛋白与白蛋白比值在中老年非肌层浸润性膀胱癌患者预后中的意义[J]. 医药论坛杂志, 2021, 42(2): 47-50.
|